2025年1月15日，欧盟食品安全局（EFSA）发布消息，欧盟食品安全局（EFSA）发布关于一种由内切-1,3（4）-β-葡聚糖酶和内切-1,4-β-木聚糖酶组成的添加剂作为家禽物种、断奶仔猪、育肥猪和母猪饲料添加剂的授权更新申请的评估。
据了解，添加剂中的内切-1,3（4）-β-葡聚糖酶和内切-1,4-β-木聚糖酶是由Talaromyces versatilis IMI CC 378536生产的。
经过评估，专家小组得出结论，在建议的使用条件下，该添加剂对目标物种、消费者和环境是安全的。在授权更新的情况下，无需评估添加剂的功效。部分原文报道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of the feed additive consisting of endo-1,3(4)-beta-glucanase and endo-1,4-beta-xylanase (produced with Talaromyces versatilis IMI CC 378536) (Rovabio® Excel) for the renewal of its authorisation as a zootechnical feed additive for all poultry species, weaned piglets, pigs for fattening and sows. The applicant provided evidence that the additive complies with the conditions of the authorisation. The FEEDAP Panel concluded that the additive in all its formulations remains safe for all poultry species, weaned piglets, pigs for fattening and sows, and remains safe for consumers and the environment. Regarding user safety, all the forms of the additive are non-irritant to the eyes or skin. Rovabio® Excel LC2 and Rovabio® Excel LC are not dermal sensitisers. Rovabio® AP and Rovabio® Excel AP T-Flex should be considered dermal sensitisers; therefore, exposure to these forms of the additive by dermal routes is considered a risk. All the forms of the additive are considered respiratory sensitisers; any exposure by inhalation is considered a risk. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
